Journal
NEURO-ONCOLOGY ADVANCES
Volume 4, Issue 1, Pages -Publisher
OXFORD UNIV PRESS
DOI: 10.1093/noajnl/vdac080
Keywords
glioblastoma (GBM); mass spectrometry; MRI; PET; radiographic progression; tumor progression
Categories
Funding
- Department of Defense [W81XWH-15-1-0108]
- U.S. Food and Drug Administration [R01FD006368, R01FD005379]
- Rally Foundation for Childhood Cancer Research
- CureSearch for Children's Cancer
- V Foundation for Cancer Research
- Hyundai Hope on Wheels
- Andrew McDonough B+ Foundation
- National Pediatric Cancer Foundation
- Pediatric Cancer Research Foundation
- Kaul Pediatric Research Institute
Ask authors/readers for more resources
Glioblastoma is the most common primary adult intracranial malignancy with poor prognosis. MRI is crucial for diagnosis, surgical planning, and post-treatment monitoring, but conventional MRI lacks information about tumor microvasculature, necrosis, or angiogenesis. Thus, developing novel imaging technologies is important for disease characterization and therapeutic development.
Glioblastoma (GBM) is the most common primary adult intracranial malignancy and carries a dismal prognosis despite an aggressive multimodal treatment regimen that consists of surgical resection, radiation, and adjuvant chemotherapy. Radiographic evaluation, largely informed by magnetic resonance imaging (MRI), is a critical component of initial diagnosis, surgical planning, and post-treatment monitoring. However, conventional MRI does not provide information regarding tumor microvasculature, necrosis, or neoangiogenesis. In addition, traditional MRI imaging can be further confounded by treatment-related effects such as pseudoprogression, radiation necrosis, and/or pseudoresponse(s) that preclude clinicians from making fully informed decisions when structuring a therapeutic approach. A myriad of novel imaging modalities have been developed to address these deficits. Herein, we provide a clinically oriented review of standard techniques for imaging GBM and highlight emerging technologies utilized in disease characterization and therapeutic development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available